Johnson & Johnson Innovation – JJDC
Overview
Johnson & Johnson Innovation – JJDC is the strategic venture capital arm of Johnson & Johnson, investing in early-stage life sciences companies across pharmaceuticals, medical devices, and consumer health sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AviadoBio | Dec 2021 | Series A | Co-investor |
| BrainsGate | Jul 2011 | VC Round | Co-investor |
| CereVasc | Jun 2026 | Series C | Co-investor |
| Hyalex Orthopaedics | Mar 2019 | Series A Extension | Co-investor |
| Hangzhou DAC Biotechnology Co., Ltd. | Jun 2022 | Strategic | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Johnson & Johnson Innovation – JJDC based?
Johnson & Johnson Innovation – JJDC is headquartered in New Brunswick, New Jersey, United States.
When was Johnson & Johnson Innovation – JJDC founded?
Johnson & Johnson Innovation – JJDC was founded in 1973.
How many portfolio companies does Johnson & Johnson Innovation – JJDC have?
Johnson & Johnson Innovation – JJDC has 46 portfolio companies in Caplight's dataset.
What are some companies in Johnson & Johnson Innovation – JJDC's portfolio?
Portfolio companies visible on Caplight include AviadoBio, BrainsGate, CereVasc, Hyalex Orthopaedics, Hangzhou DAC Biotechnology Co., Ltd..
What was Johnson & Johnson Innovation – JJDC's most recent investment shown here?
Johnson & Johnson Innovation – JJDC's most recent investment in this portfolio sample was in CereVasc in 2026.
What sectors does Johnson & Johnson Innovation – JJDC focus on?
Johnson & Johnson Innovation – JJDC focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Consumer & Commerce, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Cybersecurity, Enterprise Software, FinTech, Media, Entertainment & Gaming, Consumer & Commerce, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Healthcare & Life Sciences, Consumer & Commerce, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Johnson & Johnson Innovation – JJDC focus on?
Johnson & Johnson Innovation – JJDC typically invests at the MultiStage stage.
What is Johnson & Johnson Innovation – JJDC's AUM?
Johnson & Johnson Innovation – JJDC's assets under management are estimated between $978.2M and $3.8B.